ResMed Inc. RMD
$218.27
-$1.31-0.60%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.58% | 10.81% | 10.98% | 9.07% | 10.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.58% | 10.81% | 10.98% | 9.07% | 10.20% |
| Cost of Revenue | 14.57% | 2.84% | 2.50% | 1.47% | 3.78% |
| Gross Profit | 4.83% | 16.15% | 16.82% | 14.31% | 14.64% |
| SG&A Expenses | 10.65% | 14.06% | 14.11% | 8.46% | 9.47% |
| Depreciation & Amortization | -11.73% | 4.13% | 4.77% | 3.69% | 10.63% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.53% | 6.96% | 6.67% | 4.30% | 5.87% |
| Operating Income | -1.08% | 18.63% | 19.90% | 19.37% | 19.77% |
| Income Before Tax | 3.52% | 20.26% | 18.60% | 16.50% | 28.04% |
| Income Tax Expenses | 15.81% | 96.73% | 40.51% | 36.20% | 19.62% |
| Earnings from Continuing Operations | 0.98% | 9.23% | 13.92% | 11.94% | 29.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.98% | 9.23% | 13.92% | 11.94% | 29.93% |
| EBIT | -1.08% | 18.63% | 19.90% | 19.37% | 19.77% |
| EBITDA | -4.62% | 20.39% | 18.92% | 18.34% | 22.89% |
| EPS Basic | 2.21% | 10.27% | 14.68% | 12.46% | 30.32% |
| Normalized Basic EPS | 4.17% | 23.59% | 20.98% | 22.59% | 24.33% |
| EPS Diluted | 2.39% | 10.48% | 14.53% | 12.32% | 30.33% |
| Normalized Diluted EPS | 4.38% | 23.69% | 21.09% | 22.60% | 24.38% |
| Average Basic Shares Outstanding | -1.21% | -0.94% | -0.66% | -0.46% | -0.30% |
| Average Diluted Shares Outstanding | -1.40% | -1.02% | -0.75% | -0.47% | -0.34% |
| Dividend Per Share | 13.21% | 13.21% | 13.21% | 13.21% | 10.42% |
| Payout Ratio | 0.11% | 0.03% | -0.01% | 0.01% | -0.15% |